This study examines the updated National Comprehensive Cancer Network (NCCN) guidelines for systemic therapy in metastatic breast cancer, emphasizing the integration of tumor biology and clinical factors. As of 2023, the NCCN Guidelines Insights report provides evidence-based recommendations for stage IV breast cancer treatment, tailoring therapeutic approaches to specific disease subtypes and patient profiles, thereby optimizing clinical outcomes.